(Q39959481)
Statements
Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland (English)
M Brändle
K M Erny-Albrecht
G Goodall
G A Spinas
P Streit
W J Valentine
1 August 2009